{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-037953","form_type":"8-K","ticker":"SCNX","cik":"0001382574","company_name":"Scienture Holdings, Inc.","filed_at":"2024-09-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.847868+00:00","generated_at":"2026-05-31T02:01:18.725039+00:00","sec_items":["5.03","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"TRxADE Health renamed Scienture Holdings; ticker changes to SCNX on Nasdaq","bullets":["Name change effective September 23, 2024; new CUSIP 80880X104.","Stock now trades on Nasdaq under ticker SCNX; old ticker MEDS discontinued.","Prior all-stock business combination with Scienture LLC valued at $103 million.","Executive team and board unchanged; Suren Ajjarapu remains CEO and Chairman.","Subsidiaries include Scienture LLC (specialty pharma) and Integra Pharma Solutions (wholesale)."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-037953","json":"https://secwatch.observer/filing/0001493152-24-037953.json","markdown":"https://secwatch.observer/filing/0001493152-24-037953.md","text":"https://secwatch.observer/filing/0001493152-24-037953.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1382574/000149315224037953/0001493152-24-037953-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1382574/000149315224037953/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T02:01:18.725039+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}